James Campbell Net Worth

The estimated Net Worth of James H Campbell is at least $1.07 Milhão dollars as of 7 March 2022. James Campbell owns over 4,000 units of Hanger Inc stock worth over $920,537 and over the last 6 years he sold HNGR stock worth over $147,724. In addition, he makes $0 as Senior Vice President e Chief Clinical Officer at Hanger Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Campbell HNGR stock SEC Form 4 insiders trading

James has made over 2 trades of the Hanger Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 4,000 units of HNGR stock worth $78,080 on 7 March 2022.

The largest trade he's ever made was selling 4,000 units of Hanger Inc stock on 7 March 2022 worth over $78,080. On average, James trades about 433 units every 53 days since 2019. As of 7 March 2022 he still owns at least 49,174 units of Hanger Inc stock.

You can see the complete history of James Campbell stock trades at the bottom of the page.

James Campbell biography

Dr. James H. Campbell Ph.D. serves as Senior Vice President, Chief Clinical Officer of the Company. Previously, he held the position of Chief Clinical Officer since joining Hanger in 2015. Prior to joining Hanger, Dr. Campbell spent seventeen years with Becker Orthopedic, a leading world-wide supplier of orthotic components and central fabrication, and has forty years of experience in the Orthotics and Prosthetics profession with distinction in leadership and research. Dr. Campbell is a named inventor on five issued U.S. Patents, and has served on the Board of Directors of the American Orthotic and Prosthetic Association as well as the American Academy of Orthotists & Prosthetists (“AAOP”), from which he received the Distinguished Practitioner Award in February 2013. Dr. Campbell is a Certified Orthotist, a Fellow of the AAOP, and a member of the International Society for Prosthetics & Orthotics. Dr. Campbell holds a Higher Diploma in Prosthetics and Orthotics and a PhD in Bio-Engineering from the University of Strathclyde in Glasgow, Scotland.

How old is James Campbell?

James Campbell is 61, he's been the Senior Vice President e Chief Clinical Officer of Hanger Inc since 2018. There are 6 older and 18 younger executives at Hanger Inc. The oldest executive at Hanger Inc is Richard Pettingill, 71, who is the Independent Director.

What's James Campbell's mailing address?

James's mailing address filed with the SEC is 10910 DOMAIN DRIVE, SUITE 300, , AUSTIN, TX, 78758.

Insiders trading at Hanger Inc

Over the last 7 years, insiders at Hanger Inc have traded over $2,332,397 worth of Hanger Inc stock and bought 2,700 units worth $51,246 . The most active insiders traders include Thomas C Freyman, Stephen E Hare, eCynthia L Lucchese. On average, Hanger Inc executives and independent directors trade stock every 72 days with the average trade being worth of $339,319. The most recent stock trade was executed by Thomas E Kiraly on 15 March 2022, trading 8,750 units of HNGR stock currently worth $167,650.

What does Hanger Inc do?

About Hanger, Inc.- Hanger, Inc. delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics withapproximately 800locationsnationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With nearly 160 years of clinical excellence and innovation, Hanger's vision is to lead the orthotic and prosthetic markets by providing superior patient care, outcomes, services and value.

Complete history of James Campbell stock trades at Hanger Inc

Hanger Inc executives and stock owners

Hanger Inc executives and other stock owners filed with the SEC include:

• Vinit Asar,
  President, Chief Executive Officer, Director
• Thomas Kiraly,
  Chief Financial Officer, Executive Vice President
• Samuel Liang,
  
• Vinit K. Asar,
  CEO, Pres & Director
• Thomas Hartman,
  Senior Vice President, General Counsel, Secretary
• C. Scott Ranson,
  Executive Vice President, Corporate Services, Chief Information Officer
• Thomas E. Kiraly,
  CFO & Exec. VP
• C. Scott Ranson,
  Exec. VP of Corp. Services & Chief Information Officer
• Thomas E. Hartman,
  Sr. VP, Gen. Counsel & Sec.
• Gabrielle B. Adams,
  VP & Chief Accounting Officer
• Christopher Begley,
  Non-Executive Chairman of the Board
• Thomas Freyman,
  Independent Director
• Stephen Hare,
  Independent Director
• Richard Pettingill,
  Independent Director
• Kathryn Sullivan,
  Independent Director
• Cynthia Lucchese,
  Independent Director
• John Fox,
  Independent Director
• Asif Ahmad,
  Independent Director
• Seth Frank,
  Vice President, Treasury and Investor Relations
• Mark Jones,
  Director
• Gabrielle Adams,
  Chief Accounting Officer, Vice President
• James Campbell,
  Senior Vice President, Chief Clinical Officer
• Mitchell D. Dobson,
  Senior Vice President, Chief Compliance Officer
• Keri Jolly,
  Chief Human Resource Officer, Senior Vice President
• Peter Stoy,
  Chief Operating Officer, Executive Vice President
• Regina Weger,
  President - Products & Services
• Keri L. Jolly,
  Sr. VP & Chief HR Officer
• Krisita Burket,
  VP of PR & Communications
• Mitchell D. Dobson,
  Sr. VP & Chief Compliance Officer
• Paul Adolph Severt,
  VP of Corp. Fin. & Treasurer
• Kathleen L Means,
  Chief Supply Chain Officer
• Rebecca Hast,
  SVP, Strategic Initiatives
• Jay C Wendt,
  President, Products & Services
• Michael H Oros,
  President, Hanger Clinic